These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 7007236

  • 1. Abnormal urinary kallikrein in hypertension is not related to aldosterone or plasma renin activity.
    Lawton WJ, Fitz AE.
    Hypertension; 1980; 2(6):787-93. PubMed ID: 7007236
    [Abstract] [Full Text] [Related]

  • 2. Urinary kallikrein in normal renin essential hypertension.
    Lawton WJ, Fitz AE.
    Circulation; 1977 Nov; 56(5):856-9. PubMed ID: 912848
    [Abstract] [Full Text] [Related]

  • 3. Direct and indirect measurement of urinary kallikrein excretion in patients with essential hypertension and normotensives: relation to age and plasma renin and aldosterone levels.
    Koolen MI, Daha MR, Frölich M, Van Es LA, Van Brummelen P.
    Eur J Clin Invest; 1984 Jun; 14(3):171-4. PubMed ID: 6432545
    [Abstract] [Full Text] [Related]

  • 4. Urinary kallikrein excretion in essential and mineralocorticoid hypertension.
    Holland OB, Chud JM, Braunstein H.
    J Clin Invest; 1980 Feb; 65(2):347-56. PubMed ID: 7356684
    [Abstract] [Full Text] [Related]

  • 5. Urinary excretion of kallikrein before and after operation for aldosterone-producing adenoma.
    Hesse B, Rasmussen S, Lund JO, Christensen P, Damkjaer Nielsen M.
    Acta Med Scand; 1985 Feb; 217(5):501-5. PubMed ID: 3895826
    [Abstract] [Full Text] [Related]

  • 6. Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake.
    Levy SB, Lilley JJ, Frigon RP, Stone RA.
    J Clin Invest; 1977 Jul; 60(1):129-38. PubMed ID: 874078
    [Abstract] [Full Text] [Related]

  • 7. Non-modulating hypertension: evidence for the involvement of kallikrein/kinin activity associated with overactivity of the renin-angiotensin system. Successful blood pressure control during long-term Na+ restriction.
    Sanchez R, Gimenez MI, Ramos F, Baglivo H, Ramirez AJ.
    J Hypertens; 1996 Nov; 14(11):1287-91. PubMed ID: 8934356
    [Abstract] [Full Text] [Related]

  • 8. Potassium supplementation lowers blood pressure and increases urinary kallikrein in essential hypertensives.
    Valdés G, Vio CP, Montero J, Avendaño R.
    J Hum Hypertens; 1991 Apr; 5(2):91-6. PubMed ID: 2072372
    [Abstract] [Full Text] [Related]

  • 9. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K, Yasujima M, Chiba S, Sato M, Irokawa N, Imai Y, Yoshinaga K.
    Adv Exp Med Biol; 1979 Apr; 120B():487-501. PubMed ID: 517244
    [Abstract] [Full Text] [Related]

  • 10. Urinary kallikrein excretion in patients with primary aldosteronism: differentiation of adrenal adenoma from idiopathic adrenal hyperplasia.
    Nakada T.
    Urol Int; 1984 Apr; 39(1):40-5. PubMed ID: 6375065
    [Abstract] [Full Text] [Related]

  • 11. Increased urinary kallikrein excretion in young borderline hypertensive patients.
    Ando K, Fujita T.
    Clin Exp Hypertens A; 1983 Apr; 5(6):903-18. PubMed ID: 6349868
    [Abstract] [Full Text] [Related]

  • 12. [Mechanism of inhibition of aldosterone secretion by a Ca2+ channel blocker in patients with essential hypertension and patients with primary aldosteronism].
    Yokoyama T, Shimamoto K, Iimura O.
    Nihon Naibunpi Gakkai Zasshi; 1995 Nov 20; 71(7):1059-74. PubMed ID: 8582487
    [Abstract] [Full Text] [Related]

  • 13. Dopamine beta-hydroxylase and plasma renin activity in patients with low-, normal-, and high-renin essential hypertension.
    Lawton WJ, Fitz A, Grant C, Witte DL.
    Circulation; 1979 May 20; 59(5):1063-9. PubMed ID: 428086
    [Abstract] [Full Text] [Related]

  • 14. Urinary and renal kallikrein in hypertensive fawn-hooded (FH/Wjd) rats.
    Gilboa N, Rudofsky U, Magro A.
    Lab Invest; 1984 Jan 20; 50(1):72-8. PubMed ID: 6363817
    [Abstract] [Full Text] [Related]

  • 15. Renin-Angiotensin-Aldosterone Profiles in Pregnant Women With Chronic Hypertension.
    Malha L, Sison CP, Helseth G, Sealey JE, August P.
    Hypertension; 2018 Aug 20; 72(2):417-424. PubMed ID: 29941520
    [Abstract] [Full Text] [Related]

  • 16. [Relation of atrial natriuretic peptide, the renin-angiotensin-aldosterone system and kinin system in hypertensive and normotensive youngsters with or without a family history of essential arterial hypertension].
    Musca A, Ferri C, Cammerella I, Onofri R, Tani S, Santucci A.
    Medicina (Firenze); 1989 Aug 20; 9(2):167-72. PubMed ID: 2530412
    [Abstract] [Full Text] [Related]

  • 17. Effect of spironolactone on fluid volumes and adrenal steroids in primary aldosteronism.
    Ichikawa S, Tajima Y, Sakamaki T, Matsuo H, Kogure M, Hirano Y, Yagi S, Murata K.
    Jpn Circ J; 1984 Nov 20; 48(11):1184-96. PubMed ID: 6502914
    [Abstract] [Full Text] [Related]

  • 18. [The role of the Na, K-ATPase inhibitor in renal sodium handling in patients with essential hypertension].
    Komura H, Kikuchi K, Nozawa A, Hasegawa T, Suzuki S, Yamamoto M, Satoh N, Ohtomo T, Takada T, Iimura O.
    Nihon Jinzo Gakkai Shi; 1989 Jul 20; 31(7):775-81. PubMed ID: 2555614
    [Abstract] [Full Text] [Related]

  • 19. [Behavior of the plasma renin activity and aldosterone after salt restriction and upright posture in essential hypertension].
    Kokot F, Kuska J, Chorqzy M.
    Z Gesamte Inn Med; 1976 Dec 15; 31(24):1016-20. PubMed ID: 1020406
    [Abstract] [Full Text] [Related]

  • 20. The renin-angiotensin-aldosterone system in infancy and childhood in basal conditions and after stimulation.
    Fiselier T, Monnens L, van Munster P, Jansen M, Peer P, Lijnen P.
    Eur J Pediatr; 1984 Nov 15; 143(1):18-24. PubMed ID: 6391924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.